Clusterin solubility and aggregation in Creutzfeldt-Jakob disease

This publication has 29 references indexed in Scilit:

• Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
  Proceedings of the National Academy of Sciences, 2002
• Clusterin contributes to caspase-3–independent brain injury following neonatal hypoxia-ischemia
  Nature Medicine, 2001
• Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
  Annual Review of Neuroscience, 2001
• Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt–Jakob disease
  Neuroscience, 2000
• Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity
  Journal of Neurochemistry, 1996
• Clusterin (SGP‐2) Induction in Rat Astroglial Cells Exposed to Prion Protein Fragment 106–126
  European Journal of Neuroscience, 1996
• Apolipoprotein E and J immunoreactivity in Gerstmann-Sträussler-Scheinker disease
  Neurobiology of Aging, 1994
• Mice devoid of PrP are resistant to scrapie
  Cell, 1993
• The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
  Biochemical Journal, 1993
• SP-40,40 is a constituent of Alzheimer's amyloid
  Acta Neuropathologica, 1992